Objective: The present study was designed to evaluate the efficacy and safety of intravenously administered theophylline (IAT) for the treatment of an acute exacerbation of bronchial asthma. The theophylline was solubilized and not combined with ethylenediamine.
Methodology: The subjects were 22 asthmatic patients with mild acute exacerbation of bronchial asthma.